Viewing Study NCT01351350

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:01 PM
Ignite Modification Date: 2025-12-28 @ 9:13 AM
Study NCT ID: NCT01351350
Status: COMPLETED
Last Update Posted: 2019-08-08
First Post: 2011-02-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Malignancies View
None Hematologic Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid tumor, mTORC1/2 inhibitors, HER2 View